Literature DB >> 8880570

Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.

N J Froggatt1, C Brassett, D J Koch, D G Evans, S V Hodgson, B A Ponder, E R Maher.   

Abstract

Germline mutations in four human mismatch repair genes (MSH2, MLH1, PMS1, and PMS2) have been reported to cause hereditary non-polyposis colon cancer syndrome (HNPCC). The identification of germline mutations in HNPCC kindreds allows precise diagnosis and accurate predictive testing. To investigate further the genetic epidemiology of HNPCC and the nature and frequency of germline mutations in this disorder, we studied 17 English HNPCC kindreds for germline mutations in MSH2 and MLH1. A previous genetic linkage study had suggested that most English HNPCC families will have mutations in one of these genes. Mutation analysis was performed in a three step process. (1) mRNA extracted from lymphoblastoid cell lines was analysed for gross rearrangements, (2) the in vitro transcription-translation (IVTT) assay was then performed to detect protein truncating mutations, and (3) partial cDNA sequencing of MSH2 or MLH1 was undertaken in families (n = 6) linked to MSH2 or MLH1 but without a detectable mutation. Seven different germline mutations were identified in eight of 17 (47%) kindreds (five in MSH2 and three in MLH1). In three cases there was a deletion of a single exon in MSH2 mRNA, three mutations resulted in a truncated protein product, and two missense mutations were identified by direct sequencing. Six mutations were novel. No precise correlation between genotype and phenotype was observed, although a MSH2 missense (Thr905Arg) mutation was associated with a susceptibility to multiple colorectal polyps. Age related risks for colorectal and uterine cancer were similar for MSH2 and MLH1 mutations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880570      PMCID: PMC1050724          DOI: 10.1136/jmg.33.9.726

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  22 in total

1.  Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer.

Authors:  C E Bronner; S M Baker; P T Morrison; G Warren; L G Smith; M K Lescoe; M Kane; C Earabino; J Lipford; A Lindblom
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

2.  Mutation of a mutL homolog in hereditary colon cancer.

Authors:  N Papadopoulos; N C Nicolaides; Y F Wei; S M Ruben; K C Carter; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser; M D Adams
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

3.  Genomic structure of human mismatch repair gene, hMLH1, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC)

Authors:  H J Han; M Maruyama; S Baba; J G Park; Y Nakamura
Journal:  Hum Mol Genet       Date:  1995-02       Impact factor: 6.150

4.  Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.

Authors:  J Wijnen; H Vasen; P M Khan; F H Menko; H van der Klift; C van Leeuwen; M van den Broek; I van Leeuwen-Cornelisse; F Nagengast; A Meijers-Heijboer
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

5.  Muir-Torre syndrome: a variant of the cancer family syndrome.

Authors:  N R Hall; M A Williams; V A Murday; J A Newton; D T Bishop
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

6.  Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations.

Authors:  R D Kolodner; N R Hall; J Lipford; M F Kane; P T Morrison; P J Finan; J Burn; P Chapman; C Earabino; E Merchant
Journal:  Cancer Res       Date:  1995-01-15       Impact factor: 12.701

7.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells.

Authors:  J T Drummond; G M Li; M J Longley; P Modrich
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

8.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells.

Authors:  F Palombo; P Gallinari; I Iaccarino; T Lettieri; M Hughes; A D'Arrigo; O Truong; J J Hsuan; J Jiricny
Journal:  Science       Date:  1995-06-30       Impact factor: 47.728

9.  Mutations of two PMS homologues in hereditary nonpolyposis colon cancer.

Authors:  N C Nicolaides; N Papadopoulos; B Liu; Y F Wei; K C Carter; S M Ruben; C A Rosen; W A Haseltine; R D Fleischmann; C M Fraser
Journal:  Nature       Date:  1994-09-01       Impact factor: 49.962

10.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

View more
  9 in total

Review 1.  Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer.

Authors:  Mark A Jenkins; Melissa C Southey; Graham G Giles; John L Hopper
Journal:  Curr Oncol Rep       Date:  2007-05       Impact factor: 5.075

2.  Microsatellite instability in early onset and familial colorectal cancer.

Authors:  C Brassett; J A Joyce; N J Froggatt; G Williams; D Furniss; S Walsh; R Miller; D G Evans; E R Maher
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

3.  Splice site mutations in mismatch repair genes and risk of cancer in the general population.

Authors:  Mette Thomsen; Børge G Nordestgaard; Anne Tybjærg-Hansen; Stig E Bojesen
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

4.  Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH.

Authors:  Seyed Mohammad Akrami; Malcolm G Dunlop; Susan M Farrington; Ian M Frayling; Fiona MacDonald; John F Harvey; John A L Armour
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group.

Authors: 
Journal:  Genet Med       Date:  2000 Nov-Dec       Impact factor: 8.822

6.  Two modes of microsatellite instability in human cancer: differential connection of defective DNA mismatch repair to dinucleotide repeat instability.

Authors:  Shinya Oda; Yoshihiko Maehara; Yoichi Ikeda; Eiji Oki; Akinori Egashira; Yoshikazu Okamura; Ikuo Takahashi; Yoshihiro Kakeji; Yasushi Sumiyoshi; Kaname Miyashita; Yu Yamada; Yan Zhao; Hiroyoshi Hattori; Ken-ichi Taguchi; Tatsuro Ikeuchi; Teruhisa Tsuzuki; Mutsuo Sekiguchi; Peter Karran; Mitsuaki A Yoshida
Journal:  Nucleic Acids Res       Date:  2005-03-18       Impact factor: 16.971

7.  Cause and consequences of genetic and epigenetic alterations in human cancer.

Authors:  B Sadikovic; K Al-Romaih; J A Squire; M Zielenska
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

8.  The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Authors:  Valentina Turinetto; Paola Porcedda; Luca Orlando; Mario De Marchi; Antonio Amoroso; Claudia Giachino
Journal:  BMC Cancer       Date:  2009-08-12       Impact factor: 4.430

9.  Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.

Authors:  Dandan Li; Fulan Hu; Fan Wang; Binbin Cui; Xinshu Dong; Wencui Zhang; Chunqing Lin; Xia Li; Da Wang; Yashuang Zhao
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.